Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • SFIO probes Fortis,...

    SFIO probes Fortis, Religare for alleged frauds

    Written by Ruby Khatun Khatun Published On 2018-03-24T11:00:46+05:30  |  Updated On 24 March 2018 11:00 AM IST
    SFIO probes Fortis, Religare for alleged frauds

    New Delhi: The Serious Fraud Investigation Office (SFIO) is probing Religare Enterprises and its group company Fortis Healthcare for alleged frauds, Union Minister P P Chaudhary said.


    Besides, companies linked to Nirav Modi and Mehul Choksi groups are under the scanner too, the minister of state for corporate affairs said in a written reply to Lok Sabha.


    The development comes in the wake of over Rs 13,000 crore scam at the state-run Punjab National Bank (PNB).


    In the last four financial years, the corporate affairs ministry has ordered investigations through SFIO into the affairs of 575 companies on account of alleged frauds. This included probe in 258 companies in the ongoing financial year (till March 15, 2018), Chaudhary added.


    SFIO, which mainly investigates white collar crimes, is probing Religare and Fortis. This comes amid recent reports that financial irregularities have emerged at the two companies.


    The companies have also come under the lens of the markets regulator Sebi.


    The latest development comes against the backdrop of reports that Fortis Healthcare's promoters —Malvinder Singh and Shivinder Singh—took at least USD 78 million out of the company without any board approval about a year ago.


    Further, Chaudhary said SFIO has ordered an investigation into the affairs of companies including Firestar Diamond International, Firestar International, Firestar Diamond Pvt Ltd, Nirav Modi Pvt Ltd, Gitanjali Gems Ltd and Nakshatra Brands Ltd.


    A multi-agency probe is already underway into the PNB fraud which was mainly perpetrated by way of fraudulent Letters of Undertaking (LoUs).


    According to the minister, investigations by SFIO have not unearthed any nexus between bureaucrats and corporate houses for the purpose of committing corporate frauds as of now.

    allegedalleged fraudFortisfraudsP P ChaudharyPNBprobesPunjab National BankReligareReligare EnterprisesSerious Fraud Investigation OfficeSFIOUnion minister
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok